These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 17045617

  • 1. Role of endogenous nitric oxide (NO) and NO synthases in healing of indomethacin-induced intestinal ulcers in rats.
    Takeuchi K, Hatazawa R, Tanigami M, Tanaka A, Ohno R, Yokota A.
    Life Sci; 2007 Jan 02; 80(4):329-36. PubMed ID: 17045617
    [Abstract] [Full Text] [Related]

  • 2. Dual action of nitric oxide in pathogenesis of indomethacin-induced small intestinal ulceration in rats.
    Tanaka A, Kunikata T, Mizoguchi H, Kato S, Takeuchi K.
    J Physiol Pharmacol; 1999 Sep 02; 50(3):405-17. PubMed ID: 10574470
    [Abstract] [Full Text] [Related]

  • 3. Roles of endogenous prostaglandins and cyclooxygenase isozymes in healing of indomethacin-induced small intestinal lesions in rats.
    Hatazawa R, Ohno R, Tanigami M, Tanaka A, Takeuchi K.
    J Pharmacol Exp Ther; 2006 Aug 02; 318(2):691-9. PubMed ID: 16699067
    [Abstract] [Full Text] [Related]

  • 4. Intestinal protection by lafutidine, a histamine H(2)-receptor antagonist, against indomethacin-induced damage in rats--role of endogenous nitric oxide.
    Tanaka A, Mizoguchi H, Hase S, Miyazawa T, Takeuchi K.
    Med Sci Monit; 2001 Aug 02; 7(5):869-77. PubMed ID: 11535926
    [Abstract] [Full Text] [Related]

  • 5. Healing of duodenal ulcers is not impaired by indomethacin or rofecoxib, the selective COX-2 inhibitor, in rats.
    Araki H, Komoike Y, Matsumoto M, Tanaka A, Takeuchi K.
    Digestion; 2002 Aug 02; 66(3):145-53. PubMed ID: 12481160
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of selective and non-selective inhibition of nitric oxide synthase on the expression and activity of cyclooxygenase-2 during gastric ulcer healing.
    Guo JS, Cho CH, Wang JY, Koo MW.
    Eur J Pharmacol; 2006 May 01; 536(3):301-8. PubMed ID: 16600210
    [Abstract] [Full Text] [Related]

  • 7. Chronic administration of aminoguanidine reduces vascular nitric oxide production and attenuates liver damage in bile duct-ligated rats.
    Wei CL, Hon WM, Lee KH, Khoo HE.
    Liver Int; 2005 Jun 01; 25(3):647-56. PubMed ID: 15910502
    [Abstract] [Full Text] [Related]

  • 8. Role of endogenous nitric oxide in mucosal defense of inflamed rat stomach following iodoacetamide treatment.
    Nishio H, Hayashi Y, Terashima S, Takeuchi K.
    Life Sci; 2006 Sep 13; 79(16):1523-30. PubMed ID: 16730029
    [Abstract] [Full Text] [Related]

  • 9. Roles of nitric oxide (NO) and NO synthases in healing of dextran sulfate sodium-induced rat colitis.
    Aoi Y, Terashima S, Ogura M, Nishio H, Kato S, Takeuchi K.
    J Physiol Pharmacol; 2008 Jun 13; 59(2):315-36. PubMed ID: 18622048
    [Abstract] [Full Text] [Related]

  • 10. Nitric oxide, superoxide radicals and mast cells in pathogenesis of indomethacin-induced small intestinal lesions in rats.
    Konaka A, Nishijima M, Tanaka A, Kunikata T, Kato S, Takeuchi K.
    J Physiol Pharmacol; 1999 Mar 13; 50(1):25-38. PubMed ID: 10210152
    [Abstract] [Full Text] [Related]

  • 11. Induction of small intestinal damage in rats following combined treatment with cyclooxygenase-2 and nitric-oxide synthase inhibitors.
    Ohno R, Yokota A, Tanaka A, Takeuchi K.
    J Pharmacol Exp Ther; 2004 Aug 13; 310(2):821-7. PubMed ID: 15044560
    [Abstract] [Full Text] [Related]

  • 12. Dual role of endogenous nitric oxide in development of dextran sodium sulfate-induced colitis in rats.
    Rumi G, Tsubouchi R, Nishio H, Kato S, Mózsik G, Takeuchi K.
    J Physiol Pharmacol; 2004 Dec 13; 55(4):823-36. PubMed ID: 15613746
    [Abstract] [Full Text] [Related]

  • 13. Effect of NG-nitro-L-arginine methyl ester, the nitric oxide synthase inhibitor, on duodenal alkaline secretion and mepirizole-induced duodenal lesions in rats.
    Takeuchi K, Takehara K, Kato S.
    J Clin Gastroenterol; 1995 Dec 13; 21 Suppl 1():S66-72. PubMed ID: 8774993
    [Abstract] [Full Text] [Related]

  • 14. Endogenous prostaglandin E2 accelerates healing of indomethacin-induced small intestinal lesions through upregulation of vascular endothelial growth factor expression by activation of EP4 receptors.
    Takeuchi K, Tanigami M, Amagase K, Ochi A, Okuda S, Hatazawa R.
    J Gastroenterol Hepatol; 2010 May 13; 25 Suppl 1():S67-74. PubMed ID: 20586869
    [Abstract] [Full Text] [Related]

  • 15. Nitric oxide synthase inhibition delays axonal degeneration and promotes the survival of axotomized retinal ganglion cells.
    Koeberle PD, Ball AK.
    Exp Neurol; 1999 Aug 13; 158(2):366-81. PubMed ID: 10415143
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nitric oxide synthesis inhibition alters rat cutaneous wound healing.
    Amadeu TP, Costa AM.
    J Cutan Pathol; 2006 Jul 13; 33(7):465-73. PubMed ID: 16872468
    [Abstract] [Full Text] [Related]

  • 20. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
    Xu J, Cao H, Liu H, Wu ZY.
    Hepatobiliary Pancreat Dis Int; 2008 Oct 13; 7(5):503-8. PubMed ID: 18842497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.